Friedrich Scheiflinger

2.5k total citations
45 papers, 1.7k citations indexed

About

Friedrich Scheiflinger is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Friedrich Scheiflinger has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 22 papers in Hematology and 21 papers in Genetics. Recurrent topics in Friedrich Scheiflinger's work include Complement system in diseases (23 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers) and Platelet Disorders and Treatments (13 papers). Friedrich Scheiflinger is often cited by papers focused on Complement system in diseases (23 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers) and Platelet Disorders and Treatments (13 papers). Friedrich Scheiflinger collaborates with scholars based in Austria, United States and Italy. Friedrich Scheiflinger's co-authors include Hanspeter Rottensteiner, Barbara Plaimauer, Gerhard Antoine, Bernhard Lämmle, Birgit M. Reipert, Maurus de la Rosa, Frank Horling, Simon F. De Meyer, Jan–Dirk Studt and Klaus F. Zimmermann and has published in prestigious journals such as Blood, Nature Biotechnology and Analytical Chemistry.

In The Last Decade

Friedrich Scheiflinger

44 papers receiving 1.7k citations

Peers

Friedrich Scheiflinger
Liliane Fossati‐Jimack United Kingdom
Lacramioara Ivanciu United States
A J Fish United States
J L Preud'homme France
Jean‐Claude Bensa France
C J Elson United Kingdom
Paul Chien United States
Robin A. Pixley United States
Sylvie Jorieux France
Marion Espéli France
Liliane Fossati‐Jimack United Kingdom
Friedrich Scheiflinger
Citations per year, relative to Friedrich Scheiflinger Friedrich Scheiflinger (= 1×) peers Liliane Fossati‐Jimack

Countries citing papers authored by Friedrich Scheiflinger

Since Specialization
Citations

This map shows the geographic impact of Friedrich Scheiflinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Scheiflinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Scheiflinger more than expected).

Fields of papers citing papers by Friedrich Scheiflinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Scheiflinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Scheiflinger. The network helps show where Friedrich Scheiflinger may publish in the future.

Co-authorship network of co-authors of Friedrich Scheiflinger

This figure shows the co-authorship network connecting the top 25 collaborators of Friedrich Scheiflinger. A scholar is included among the top collaborators of Friedrich Scheiflinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrich Scheiflinger. Friedrich Scheiflinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rossato, Paolo, Helmut Glantschnig, Fabio Canneva, et al.. (2023). Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease. Journal of Thrombosis and Haemostasis. 21(2). 269–275. 5 indexed citations
2.
Rossato, Paolo, Enrica Federti, Alessandro Mattè, et al.. (2022). Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease. Haematologica. 107(11). 2650–2660. 13 indexed citations
3.
Rossato, Paolo, Helmut Glantschnig, Tanja Ruthsatz, et al.. (2021). Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey. Blood Coagulation & Fibrinolysis. 33(1). 56–60. 3 indexed citations
4.
Konkle, Barbara A., Christopher Walsh, Miguel A. Escobar, et al.. (2020). BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression. Blood. 137(6). 763–774. 138 indexed citations
5.
Lengler, Johannes, et al.. (2020). Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release. Molecular Therapy — Methods & Clinical Development. 17. 581–588. 14 indexed citations
6.
Rottensteiner, Hanspeter, Birgit Seyfried, Stefan Kaufmann, et al.. (2019). Identification of cysteine thiol‐based linkages in ADAMTS13 in support of a non‐proteolytic regulation of von Willebrand factor. Journal of Thrombosis and Haemostasis. 17(12). 2099–2109. 7 indexed citations
7.
Bunk, Sebastian, Padmapriya Ponnuswamy, Mantas Mališauskas, et al.. (2018). IVIG induces apoptotic cell death in CD56dim NK cells resulting in inhibition of ADCC effector activity of human PBMC. Clinical Immunology. 198. 62–70. 9 indexed citations
8.
Weber, Alfred, et al.. (2018). Development of Methods for the Selective Measurement of the Single Amino Acid Exchange Variant Coagulation Factor IX Padua. Molecular Therapy — Methods & Clinical Development. 10. 29–37. 8 indexed citations
9.
Denorme, Frederik, Friederike Langhauser, Linda Desender, et al.. (2016). ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice. Blood. 127(19). 2337–2345. 130 indexed citations
10.
Allacher, Peter, Maurus de la Rosa, Alexander Bauer, et al.. (2016). The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?. Pharmaceutical Research. 33(9). 2239–2249. 136 indexed citations
11.
Kaufmann, Stefan, et al.. (2015). Temperature-Dependent Irreversible Conformational Change of ADAMTS13 upon Metal Ion Chelation. Blood. 126(23). 2238–2238. 2 indexed citations
12.
Mališauskas, Mantas, et al.. (2015). A Flow-Cytometry-Based Approach to Facilitate Quantification, Size Estimation and Characterization of Sub-visible Particles in Protein Solutions. Pharmaceutical Research. 32(9). 2863–2876. 11 indexed citations
13.
Ferrari, Silvia, Johanna A. Kremer Hovinga, Paul Knöbl, et al.. (2013). Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura. Haematologica. 99(4). 779–787. 46 indexed citations
14.
Zhang, Zhenqing, Susanne Till, Sabine Knappe, et al.. (2013). Structure-activity relationship of the pro- and anticoagulant effects of Fucus vesiculosus fucoidan. Thrombosis and Haemostasis. 112(3). 429–437. 65 indexed citations
15.
Seyfried, Birgit, Martina Marchetti‐Deschmann, Jürgen Siekmann, et al.. (2012). Microchip capillary gel electrophoresis of multiply PEGylated high‐molecular‐mass glycoproteins. Biotechnology Journal. 7(5). 635–641. 10 indexed citations
16.
Saeki, Takako, Tomoyuki Ito, Hajime Ishiguro, et al.. (2011). Thrombotic thrombocytopenic purpura in IgG4‐related disease with severe deficiency of ADAMTS‐13 activity and IgG4 autoantibody against ADAMTS‐13. Arthritis Care & Research. 63(8). 1209–1212. 10 indexed citations
17.
Noris, Marina, Miriam Galbusera, Roberta Donadelli, et al.. (2005). Complement Factor H Mutation in Familial Thrombotic Thrombocytopenic Purpura with ADAMTS13 Deficiency and Renal Involvement. Journal of the American Society of Nephrology. 16(5). 1177–1183. 104 indexed citations
18.
Galbusera, Miriam, Elena Bresin, Marina Noris, et al.. (2005). Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report. Blood. 106(3). 925–928. 40 indexed citations
19.
Studt, Jan–Dirk, Johanna A. Kremer Hovinga, Gerhard Antoine, et al.. (2004). Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin. Blood. 105(2). 542–544. 117 indexed citations
20.
Antoine, Gerhard, Klaus F. Zimmermann, Barbara Plaimauer, et al.. (2003). ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor‐cleaving protease activity by recombinant human ADAMTS13. British Journal of Haematology. 120(5). 821–824. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liliane Fossati‐Jimack Breakdown of academic impact, for papers by Lacramioara Ivanciu Breakdown of academic impact, for papers by A J Fish Breakdown of academic impact, for papers by J L Preud'homme Breakdown of academic impact, for papers by Jean‐Claude Bensa Breakdown of academic impact, for papers by C J Elson Breakdown of academic impact, for papers by Paul Chien Breakdown of academic impact, for papers by Robin A. Pixley Breakdown of academic impact, for papers by Sylvie Jorieux Breakdown of academic impact, for papers by Marion Espéli
Rankless by CCL
2026